Zenobia Pharmaceuticals Private Limited, a active private limited company, was established on 23 July 2010 in Kozhikode, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233KL2010PTC026403. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.20 M.
It upholds a compliant status. Its leadership includes Ramanan Sankara (Managing Director), Biju Kallazhy (Director), Sreekumar Dharmaraj (Director). Past directors included Ramanan Sankara, Cyriac Mathew Palamthattel. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Door No 67/1625, 67/1625A, Thoppayil, Near Delux Community Hall, North Beach Road, Kozhikode, Kerala, 673011.
U24233KL2010PTC026403
026403
23 July 2010
₹5.00 M
₹4.20 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Zenobia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramanan Sankara | Managing Director | 23 Jul 2010 | Current |
| Biju Kallazhy | Director | 23 Jul 2010 | Current |
| Sreekumar Dharmaraj | Director | 23 Jul 2010 | Current |
| Kavungal Ram Mohan Chellan | Director | 24 Jan 2019 | Current |
| Anandan Elambilathodi Raman | Director | 24 Jan 2019 | Current |
| Dharmaraj Mahesh Kumar | Director | 24 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Sep 2014 | Past |
| Pramod Abcsdd | Managing Director | 30 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zenobia Pharmaceuticals Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 0.1% decrease. The company also saw a substantial fall in profitability, with a 1901.32% decrease in profit. The company's net worth Soared by an impressive increase of 18.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Zenobia Pharmaceuticals had a promoter holding of 39.52% and a public holding of 60.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Zenobia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zenobia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenobia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Zenobia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Zenobia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ernakulam. was recorded as a recent event.
The activity Kavungal Ram Mohan Chellan was appointed as a Director was appointed as a Director on 24 Jan 2019 & has been associated with this company since 6 years 11 months . was completed.
The activity Anandan Elambilathodi Raman was appointed as a Director was appointed as a Director on 24 Jan 2019 & has been associated with this company since 6 years 11 months . was completed.
Progress on Dharmaraj Mahesh Kumar was appointed as a Director was appointed as a Director on 24 Jan 2019 & has been associated with this company since 6 years 11 months . was documented.
Progress on Ramanan Sankara was appointed as a Managing Director was appointed as a Managing Director on 23 Jul 2010 & has been associated with this company since 15 years 5 months . was documented.
The CIN of Zenobia Pharmaceuticals Private Limited is U24233KL2010PTC026403.
Zenobia Pharmaceuticals Private Limited is headquartered at Door No 67/1625, 67/1625A, Thoppayil, Near Delux Community Hall, North Beach Road, Kozhikode, Kerala, 673011.
Zenobia Pharmaceuticals Private Limited was incorporated on 23 July 2010.
The current directors of Zenobia Pharmaceuticals Private Limited are
The primary industry of Zenobia Pharmaceuticals Private Limited is Manufacturing.
Zenobia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zenobia Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹4.20 M.
The compliance status of Zenobia Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX